Enterobacter k5, microbial agents and their applications

By screening Enterobacter K5 from the fermentation environment of cigar tobacco leaves to prepare microbial inoculants, the technical challenges of reducing NNK content and improving aroma quality during cigar fermentation have been solved. This has achieved stable degradation of NNK and improved the sensory quality of tobacco products, making it a green, convenient, and convenient method for reducing harm and enhancing aroma in cigar tobacco leaves.

CN123063302APending Publication Date: 2026-11-10HENAN AGRICULTURAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610854690.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2026-05-22
Filing Date
2026-06-13
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing technologies for reducing NNK content in tobacco products have technical problems such as the risk of chemical residues, damage to aroma quality, poor microbial adaptability, weak colonization ability, unstable NNK reduction effect, and difficulty in achieving both harm reduction and aroma enhancement.

Method used

A microbial agent was prepared using Enterobacter K5, which was screened from the fermentation environment of cigar tobacco leaves. It was inoculated during the fermentation process of cigar tobacco leaves. By utilizing its stable colonization in the cigar fermentation environment and its metabolic synergistic effect with the tobacco substrate, the content of NNK was significantly reduced and the aroma quality was improved.

Benefits of technology

It achieves a significant improvement in the sensory quality of cigar tobacco leaves while reducing NNK content, enhancing the smoking safety and aroma characteristics of tobacco products, avoiding the risk of chemical residues, and is easy to operate and suitable for large-scale industrial application.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123063302A_ABST
    Figure CN123063302A_ABST
Patent Text Reader

Abstract

This invention relates to a strain of *Enterobacterium arvense* K5, a microbial agent, and their application, aiming to solve the technical problems in existing cigar fermentation systems that involve chemical residue risks, damage to aroma quality, poor microbial adaptability, weak colonization ability, unstable NNK reduction effects, and difficulty in simultaneously achieving both harm reduction and aroma enhancement when reducing NNK content. This application isolates and screens a strain of *Enterobacterium arvense* K5 from the fermentation environment of cigar tobacco leaves. Enterobacter asburiae Enterobacter K5, with accession number CCTCC NO: M 20252249, was prepared as a microbial inoculant and applied during the fermentation process of cigar tobacco leaves. This Enterobacter K5 can stably colonize in the cigar fermentation environment, significantly reducing the content of tobacco-specific nitrosamine NNK, while simultaneously improving the aroma quality of cigar tobacco leaves. It achieves a synergistic effect of reducing harmful substances and enhancing aroma in cigar tobacco leaves, and is characterized by its green and safe nature, ease of operation, and suitability for industrial-scale application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of microbial fermentation technology, specifically to Enterobacter oryzae K5, microbial inoculants, and their applications. Background Technology

[0002] Tobacco-specific nitrosamines (TSNAs) are a group of carcinogens of great concern in tobacco products, mainly formed by the reaction of alkaloids in tobacco leaves with nitrosating agents during processing and storage. Among them, 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone (NNK) is one of the most representative potent carcinogens among TSNAs, and its content directly affects the smoking safety and sensory quality of tobacco products (especially cigars). Cigars employ a long-cycle fermentation process, and under the conditions of high temperature and humidity and microbial community succession, there is a risk of secondary synthesis or precursor transformation of NNK in the tobacco leaves. Therefore, effectively blocking the formation of NNK or promoting its degradation has become a core technical challenge for the tobacco industry to improve product safety.

[0003] Currently, the main technical means to reduce the NNK content in tobacco products are divided into physicochemical methods and biological methods. Physicochemical methods often use additives (such as vitamin C and tea polyphenols) to inhibit nitrosation, or reduce the accumulation of TSNA precursors by improving the drying and curing processes. Biological methods focus on using the metabolic activity of microorganisms to intervene in the synthesis pathway of TSNA, such as using Bacillus and other microorganisms to degrade nicotine or nitrates during tobacco fermentation to indirectly reduce the total amount of TSNA, or screening for microbial strains that can directly degrade NNK. Some patent documents also describe technical solutions for directly spraying microbial agents onto the surface of tobacco leaves to control TSNA content by competitively inhibiting or secreting functional enzyme systems.

[0004] However, the application of existing technologies in cigar fermentation systems still has significant shortcomings. While physicochemical methods have a certain inhibitory effect, they pose a risk of chemical residues and may disrupt the balance of aroma compounds in cigar tobacco leaves, affecting their original taste and aroma characteristics. Existing biological methods mostly focus on common functional bacteria such as Bacillus, which have poor adaptability to the special environment of cigar fermentation, weak strain colonization ability, and unstable NNK reduction effects. In addition, most existing microbial agents only focus on the degradation efficiency of NNK, neglecting the metabolic synergy between microorganisms and tobacco substrates during cigar fermentation, making it difficult to maintain or improve the aroma quality of cigar tobacco leaves while reducing NNK content. Therefore, there is an urgent need in this field to develop a microorganism and its agent that can effectively adapt to the cigar fermentation environment, stably reduce NNK content, and not affect tobacco quality.

[0005] The information disclosed in this background section is intended only to enhance the understanding of the background technology of this disclosure and should not be construed as an admission or in any way implying that the information constitutes prior art known to those skilled in the art. Summary of the Invention

[0006] This invention addresses the technical problems in existing cigar fermentation systems, such as the risk of chemical residues, damage to aroma quality, poor microbial adaptability, weak colonization ability, unstable NNK reduction effects, and difficulty in simultaneously achieving both harm reduction and aroma enhancement. It employs a strain of *Enterobacterium arachnoideum* isolated and screened from the cigar tobacco fermentation environment that can efficiently adapt to cigar fermentation systems. Enterobacter asburiae The key technology of preparing K5 into a microbial agent and applying it during the fermentation process of cigar tobacco leaves has achieved the effect of stable colonization of this functional strain in the cigar fermentation environment, significantly reducing the content of tobacco-specific nitrosamine NNK, and improving the aroma quality of cigar tobacco leaves, thus realizing the synergistic effect of reducing harm and enhancing aroma in cigar tobacco leaves.

[0007] To achieve the above-mentioned objectives, the technical solution adopted by this invention is as follows: Provides a strain of Enterobacter aegyptia Enterobacter asburiae K5, deposited at the China Center for Type Culture Collection, with accession number CCTCC NO: M 20252249.

[0008] The present invention also provides a microbial inoculant containing at least one of the following: live Enterobacter K5, fermentation broth, bacterial suspension, lyophilized powder, or immobilized bacterial cells.

[0009] Preferably, the effective viable count of Enterobacter K5 in the microbial agent is not less than 1×10⁻⁶. 8 CFU / mL or 1×10 8 CFU / g.

[0010] The present invention also provides a method for preparing the aforementioned microbial inoculant, comprising the following steps: (1) The Enterobacter aegypti K5 strain was inoculated into NA liquid medium and cultured with shaking at 25-30℃ for 10-14 h to obtain seed culture; (2) The obtained seed culture was inoculated into NA liquid medium at a volume ratio of 1 to 5%, and cultured with shaking at 25 to 30°C for 10 to 14 h to obtain the culture; (3) The culture obtained in step (2) can be used directly as a liquid microbial agent, or after concentration, drying and / or immobilization, it can be made into other dosage forms of microbial agents.

[0011] Preferably, the NA liquid culture medium contains, in g / L, 2-4 parts beef extract, 8-12 parts peptone, and 4-6 parts NaCl.

[0012] The present invention also provides the use of the aforementioned Enterobacter K5 or the aforementioned microbial agent in the degradation of tobacco-specific nitrosamines and / or the improvement of the quality of tobacco products.

[0013] Preferably, the application includes at least one of the following: (1) Degrading NNK in tobacco products; (2) Reduce TSNA in tobacco products; (3) Reduce the total sugar content in tobacco products; (4) Reduce the nicotine content in tobacco products; (5) Improve the sensory quality of tobacco products.

[0014] Preferably, the sensory qualities include at least one of the following: off-flavors, irritation, aftertaste, strength, and smoothness.

[0015] The present invention also provides a method for reducing the NNK content in cigar tobacco leaves, wherein the microbial agent is evenly sprayed onto the cigar tobacco leaves and then sealed, and fermented at 33-37°C and 65-75%RH.

[0016] Preferably, the amount of the microbial agent applied to the cigar tobacco leaves is 30-40% of the dry weight of the cigar tobacco leaves to be treated, and the fermentation time is 3-5 days.

[0017] One or more technical solutions provided in the embodiments of this application have at least one of the following technical effects or advantages: 1. Significantly reduce NNK content and achieve harm reduction goals: The Enterobacter albopictus K5 obtained by screening in this invention is derived from the fermentation environment of cigar tobacco leaves. It has good native adaptability and colonization ability. It can stably colonize and continuously perform metabolic functions in the high temperature, high humidity and complex microbial community environment unique to cigars, effectively blocking the generation of NNK or promoting its degradation, significantly reducing the content of tobacco-specific nitrosamine NNK in cigar tobacco leaves, and effectively improving the smoking safety of tobacco products.

[0018] 2. Synergistic enhancement of aroma quality, achieving enhanced aroma and efficacy: While reducing the NNK content, this invention fully utilizes the metabolic synergy between Enterobacter oryzae K5 and the cigar tobacco matrix to effectively improve the sensory quality of cigar tobacco. Specifically, it reduces off-flavors, decreases irritation, provides a pleasant aftertaste, moderates strength, and enhances smoothness. It maintains and optimizes the original aroma characteristics of cigar tobacco, breaking through the dual bottleneck of existing technologies that struggle to balance harm reduction and aroma enhancement, and achieving a significant synergistic effect.

[0019] 3. Green, safe, and easy to operate: This invention uses microbial agents for biological control, requiring no chemical additives throughout the process. This avoids the chemical residue risks associated with traditional physicochemical methods, aligning with the development trend of green and safe practices. Furthermore, the agent preparation process is mature; inoculation can be achieved simply by spraying during fermentation, making it easy to operate and suitable for large-scale industrial application.

[0020] In summary, this invention achieves a green, efficient, and convenient technological breakthrough in reducing harm and enhancing aroma in cigar tobacco leaves by screening Enterobacter K5 derived from the cigar fermentation environment and preparing it into a microbial agent. This breakthrough stabilizes and reduces NNK content while synergistically improving aroma quality. Attached Figure Description

[0021] Figure 1 This is the morphological identification result of strain K5 in one embodiment of this application.

[0022] Figure 2 This is a phylogenetic tree of strain K5 in one embodiment of this application.

[0023] Figure 3 This is an example of an NNK standard curve established based on HPLC in one embodiment of this application.

[0024] Figure 4 The results of NNK determination based on HPLC are shown in one embodiment of this application; wherein CK is the control group, K5-SY is the microbial fermentation broth, and K5-MY is the extracellular crude enzyme solution.

[0025] Figure 5 The NNK content of cigar tobacco leaves under different treatments in one embodiment of this application is shown; wherein CK is the control group, K5-SY is the microbial fermentation broth, and K5-MY is the extracellular crude enzyme solution.

[0026] Figure 6 The results of total sugar content determination of cigar tobacco leaves in one embodiment of this application are shown; wherein CK is the control group, T1 is the microbial fermentation broth, and T2 is the extracellular crude enzyme solution.

[0027] Figure 7 The results of nicotine content determination in cigar tobacco leaves are shown in one embodiment of this application; where CK is the control group, T1 is the microbial fermentation broth, and T2 is the extracellular crude enzyme solution. Detailed Implementation

[0028] The following examples illustrate specific implementations of the present invention. However, these examples are merely for illustrative purposes and do not limit the scope of the invention in any way.

[0029] Unless otherwise specified, the instruments and equipment involved in the following embodiments are all conventional instruments and equipment; unless otherwise specified, the reagents and materials involved are all commercially available conventional products; unless otherwise specified, the test and detection methods involved are all conventional methods.

[0030] Example 1: Acquisition and Species Identification of Strains 1. Sample source: The sample used in the experiment was cigar tobacco leaves produced in Baise, Guangxi (collector: Wang Zhenhua; collection location: tobacco planting base in Baise City, Guangxi; collection time: June 2024).

[0031] 2. Separation and purification steps 2.1 Culture medium NA solid culture medium: beef extract 3 g / L, peptone 10.0 g / L, NaCl 5.0 g / L, agar powder 20.0 g / L, pH natural, autoclaved at 121℃ for 20 min; NA liquid culture medium: beef extract 3 g / L, peptone 10.0 g / L, NaCl 5.0 g / L, pH at rest, autoclaved at 121℃ for 20 min; LB liquid medium: NaCl 10 g / L, peptone 10 g / L, yeast extract 5 g / L; Sodium nitrite solid culture medium: K2HPO4 13.3 g / L, KH2PO4 4.0 g / L, sodium nitrite 0.10 g / L, glucose 10.0 g / L, MnSO4 0.0218 g / L, CaCl2 0.0151 g / L, FeSO4 0.0109 g / L, agar 20 g / L; 4-Methylnitrosamine-1-3-pyridyl-1-butanone glycosides: K2HPO4 13.3 g / L, KH2PO4 4.0 g / L, 4-methylnitrosamine-1-3-pyridyl-1-butanone 10 mg / L, glucose 10.0 g / L, MnSO4 0.0218 g / L, CaCl2 0.0151 g / L, FeSO4 0.0109 g / L, agar 20 g / L.

[0032] 2.2 Test Reagents 4-Methylnitrosamine-1-3-pyridyl-1-butanone (NNK, molecular weight: 207.23), DMSO solution, acetonitrile.

[0033] 2.3 Strain screening Weigh 2 g of tobacco leaves or grind the tobacco leaves into powder and transfer them to 50 mL of sterile water. Place the sample solution in a constant temperature shaker and incubate at 30℃ and 180 r / min for 36 h. After incubation, perform 10 tests on the bacterial suspension.-1 10 -2 10 -3 Dilute the bacterial suspension by 50 μL and spread it evenly on the surface of sodium nitrite solid medium. Then, incubate the medium at 25°C for 48-96 h, observing colony formation periodically. Finally, select bacteria that grow well and exhibit strong viability on the medium and aseptically transfer them to NA medium for preservation.

[0034] 2.4 Secondary screening of strains The strains initially screened and preserved on NA medium were inoculated onto 4-methylnitrosamine-1,3-pyridyl-1-butanone medium using an inoculation loop in a clean bench and stored at 25°C for 72-96 h. Colonies that grew vigorously on 4-methylnitrosamine-1,3-pyridyl-1-butanone medium were selected and preserved on NA medium. Single colonies were obtained after repeated streaking.

[0035] 3. Strain identification Morphological and physiological / biochemical identification: The screened strains were inoculated into NA solid medium and incubated at 30°C for 24 h. The colony morphology was observed and the cell characteristics were examined under an electron microscope. The morphology and physiological / biochemical identification of the strains were performed in accordance with Bergey's Manual of Bacteriological Identification and the Manual of Systematic Identification of Common Bacteria. Figure 1 (and Table 1).

[0036] Table 1 Biochemical characteristics of strains

[0037] After culturing strain K5 in NA medium for 36 hours, the colonies were all round, milky white, with a smooth and glossy surface, opaque, with a raised center, regular edges, and were moist and difficult to pick up. Figure 1 ).

[0038] Molecular biological identification: The strain was inoculated into NA solid medium and cultured at 30℃ and 180 r / min for 24 h. After the culture was completed, 10 µl of bacterial culture was transferred into a PCR tube, heated at 95℃ for 7 min in a PCR instrument, and centrifuged at 10000 r / min at 4℃ for 10 min. The supernatant was then used as a DNA template. Using the strain's genomic DNA as a template, the 16S rDNA sequence was amplified using universal primers 27F (5′-AGAGTTTGATCMTGGCTCAG-3′) and 1492R (5′-GGTTACCTTGTTACGACTT-3′). The PCR amplification system consisted of 25 µL of 2×Taq Master Mix, 2 µL each of forward and reverse primers (10 µmol / L), 2 µL of DNA template, and 19 µL of ddH2O. The PCR reaction program was as follows: 94℃ pre-denaturation for 3 min; 94℃ denaturation for 30 s, 55℃ annealing for 30 s, and 72℃ extension for 1 min, for 30 cycles; 72℃ extension for 5 min; and finally, storage at 4℃. The PCR products were sequenced by Sangon Biotech (Shanghai) Co., Ltd. The sequencing results were compared with known sequences in the NCBI database using the NCBI BLAST online tool, and a phylogenetic tree of the strain was constructed using Mega 5.0 software.

[0039] Through systemic evolutionary analysis (see...) Figure 2 ), showing that strain K5 and Enterobacter asburiae Homologous, meaning most closely related to *Enterobacter argentea*. Ultimately, strain K5 was identified as *Enterobacter argentea*. Enterobacter asburiae ), named Enterobacter asburiae K5 is currently deposited at the China Center for Type Culture Collection (address: Wuhan University, Wuhan, China, 430072, China), with accession number CCTCC NO: M 20252249 and deposit date of October 20, 2025.

[0040] Example 2: Verification of the degradation ability of Enterobacter K5 on NNK 1. The preparation steps of the microbial inoculant based on strain K5 are as follows: (1) Activation of strain: Enterobacter aureus K5 strain was inoculated into NA solid medium by spot inoculation and cultured at 30℃ for 24-72 h; (2) Seed culture preparation: scrape the bacterial cells cultured in step (1), inoculate them into NA liquid medium, and culture them in a shaker at 30℃ and 180r / min for 12 h to obtain the seed culture; (3) Preparation of microbial fermentation broth: The seed liquid obtained in step (2) is inoculated into NA medium at an inoculation rate of 3%, and cultured at 30℃ and 180 r / min for 48 h with shaking to obtain the fermentation broth; (4) Preparation of extracellular crude enzyme solution: Take the fermentation broth obtained in step (3), centrifuge at 4℃ and 8000 r / min for 10 min, collect the supernatant and filter it through a 0.22 μm filter membrane to obtain the extracellular crude enzyme solution; (5) Fermentation treatment: T1 (K5-SY): Take the fermentation broth obtained in step (3) directly as the bacterial culture fermentation sample; T2 (K5-MY): Take the extracellular crude enzyme solution obtained in step (4) as the fermentation sample.

[0041] 2. Analysis of the degradation characteristics of NNK by the strain The content of NNK was determined by high performance liquid chromatography (HPLC), and a standard curve for this substance was established. Figure 3 Quantification was then performed. The method for treating tobacco-specific nitrosamine NNK standards using the aforementioned bacterial culture and extracellular crude enzyme solution includes the following steps: reacting 5% of the obtained T1 (K5-SY) and T2 (K5-MY) solutions with NNK at a final concentration of 10 ppm, and then determining the content of tobacco-specific nitrosamine NNK to assess the degradation effect. Results are as follows... Figure 4 As shown, the fermentation products of Enterobacter K5 strain have a significant ability to inhibit or transform NNK: compared with the untreated CK group, both T1 and T2 groups showed a significant decrease in concentration (approximately 30%), indicating that the metabolites or enzymes in the fermentation broth of Enterobacter K5 strain can effectively reduce the level of NNK-related metabolites.

[0042] Synergistic effect of Enterobacter aegyptiacus K5 strain cells and supernatant: Although both are effective, K5-SY is slightly better than K5-MY, suggesting that in practical applications, it may be necessary to consider retaining some cells or specific cell components to obtain the best degradation effect.

[0043] Comparison of NNK content in cigar tobacco leaves before fermentation, CK, T1 (K5-SY), and T2 (K5-MY) treatments. Figure 5 After optimization, cigar tobacco leaves treated with *Enterobacter pylori* K5 extracellular crude enzyme solution showed a significant decrease in NNK content compared to before enzyme inoculation (approximately 0.95 mg / L). In group T2 (extracellular crude enzyme supernatant): NNK content was approximately 0.85 mg / L, a decrease of approximately 10.5%; in group T1 (bacterial solution): NNK content was approximately 0.78 mg / L, a decrease of approximately 17.9%; in group CK (control group): NNK content was approximately 0.98 mg / L, showing a slight increase, indicating that simple water spraying had no degradation effect.

[0044] Implementation 3: The impact of microbial agents on the chemical composition and sensory quality of tobacco leaves 1. Total sugar content determination: The changes in total sugar content of tobacco leaves before fermentation, and under CK, T1, and T2 treatments were detected using a flow analyzer. Figure 6 As shown, the total sugar content was highest before fermentation, at approximately 1.48%. After fermentation, the total sugar content of groups CK, T1, and T2 decreased sequentially, to approximately 1.45%, 1.38%, and 1.37%, respectively. This indicates that the fermentation process consumes total sugar, and the degree of consumption varies among different treatments. The MY treatment showed the most significant effect on total sugar consumption, and overall, the total sugar content gradually decreased after fermentation.

[0045] 2. Nicotine content determination: Changes in nicotine content in tobacco leaves before fermentation, and at the CK, T1, and T2 treatments were detected using a flow analyzer. Figure 7 As shown, the nicotine content was highest before fermentation, approximately 2.3%. After fermentation, the nicotine content in the CK, T1, and T2 groups continuously decreased, to approximately 2.2%, 2.1%, and 1.93%, respectively, with the MY group showing the largest decrease. This indicates that fermentation and subsequent treatments can effectively degrade nicotine, and the degradation effects of different treatments vary. The T2 treatment showed a significantly better degradation effect on nicotine than the CK and T1 groups, and the overall trend was a gradual decrease in nicotine content as the treatment progressed.

[0046] 3. Sensory Quality Evaluation: The method for treating cigar tobacco leaves with the aforementioned extracellular crude enzyme solution to reduce the content of tobacco-specific nitrosamine NNK in cigar tobacco leaves includes the following steps: uniformly spraying the obtained 20% T1 and T2 solutions at 35% of the dry weight of the cigar tobacco leaves in the form of a spray, sealing the leaves in a double-layer sealed bag, and fermenting them at 35℃ and 70%RH for 3-5 days to obtain cigar tobacco leaves treated with the extracellular crude enzyme solution. The content of tobacco-specific nitrosamine NNK is measured to determine the degradation effect. Then, chemical routine tests are performed, and the leaves are rolled for sensory evaluation.

[0047] The results (see Table 2) showed that the sensory quality of tobacco leaves was significantly improved after treatment with the microbial agent. Compared with the pre-fermentation and control groups (CK), the T2 treatment showed the best effect, with the total score increasing from 61.0 points before fermentation to 67.5 points, an increase of 6.5 points compared with CK (61.0 points). The total score of the T1 treatment was 63.0 points, which was also better than the pre-fermentation and CK treatments. The total score of CK was the same as that before natural fermentation, indicating that natural fermentation did not produce a significant quality improvement effect during this fermentation cycle.

[0048] Table 2 Sensory evaluation results of cigar tobacco leaves after fermentation

[0049] From the perspective of individual indicators, the most significant improvements in irritation, bitterness, and spiciness were observed in the treated tobacco leaves. Specifically, the irritation score of the T2 treatment increased from 5.0 before fermentation to 5.5, bitterness significantly improved from 5.0 to 6.0, and spiciness increased from 4.0 to 6.0. This indicates that the extracellular crude enzyme solution effectively degraded nitrogenous irritating substances such as tobacco-specific nitrosamines, significantly reducing smoke irritation and improving oral comfort. Simultaneously, the aroma quality of the T2 treatment improved from 4.0 to 5.0, aroma quantity from 4.0 to 5.0, smoothness from 4.0 to 5.0, aftertaste remained stable at 5.0, grayness improved from 4.0 to 5.0, and smoothness improved from 4.0 to 4.5. The harmony, richness, and appearance quality of the smoke all showed varying degrees of improvement.

[0050] In contrast, although the T1 treatment had a better total score (63.0) than the CK, it showed a significant decrease in strength (from 4.5 before fermentation to 3.0), and the aroma (4.0) was also lower than the CK (5.0). This suggests that the enzymatic reaction at this treatment concentration may have over-degraded some alkaloid components, resulting in insufficient strength and limited improvement in overall quality.

[0051] It is worth noting that the T2 treatment showed a slight decrease in combustibility (4.0) and flammability (4.0) compared to the unfermented (4.5, 5.0) and control (CK) grades (4.5, 5.0), and its smoothness (4.5) was also slightly lower than that of T1 (5.0). This may be related to changes in the local moisture content of the tobacco leaves after enzyme spraying or the loss of some low-boiling-point volatile aroma substances during enzymatic hydrolysis. However, overall, the T2 treatment showed significant gains in core sensory indicators such as reducing irritation, alleviating bitterness, and improving aroma and mellowness. The overall harmony of the smoke and the smoking comfort were greatly improved, resulting in the best overall quality improvement effect.

[0052] Although some preferred embodiments of the invention have been described, those skilled in the art, upon learning the basic inventive concept, can make other changes and modifications to these embodiments. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments as well as all changes and modifications falling within the scope of the invention.

[0053] Obviously, those skilled in the art can make various modifications and variations to this invention without departing from its spirit and scope. Therefore, if these modifications and variations fall within the scope of the claims of this application and their equivalents, this invention is also intended to include these modifications and variations.

Claims

1. A type of Enterobacter acetylcholine ( Enterobacter asburiae K5, characterized in that, It is deposited at the China Center for Type Culture Collection, with accession number CCTCC NO: M 20252249.

2. A microbial inoculant, characterized in that, It contains at least one of the following: live Enterobacter K5 as described in claim 1, fermentation broth, bacterial suspension, lyophilized powder, or immobilized bacterial cells.

3. The microbial agent according to claim 2, characterized in that, The effective viable count of Enterobacter K5 in the microbial agent is not less than 1×10⁻⁶. 8 CFU / mL or 1×10 8 CFU / g.

4. A method for preparing the microbial inoculant as described in claim 2 or 3, characterized in that, Includes the following steps: (1) The Enterobacter k5 strain of claim 1 is inoculated into NA liquid medium and cultured with shaking at 25-30°C for 10-14 h to obtain seed culture; (2) The obtained seed culture was inoculated into NA liquid medium at a volume ratio of 1 to 5%, and cultured with shaking at 25 to 30°C for 10 to 14 h to obtain the culture; (3) The culture obtained in step (2) can be used directly as a liquid microbial agent, or after concentration, drying and / or immobilization, it can be made into other dosage forms of microbial agents.

5. The preparation method according to claim 4, characterized in that, The NA liquid culture medium contains, in g / L, 2-4 g of beef extract, 8-12 g of peptone, and 4-6 g of NaCl.

6. The use of the Enterobacter K5 of claim 1 or the microbial agent of claim 2 in the degradation of tobacco-specific nitrosamines and / or the improvement of the quality of tobacco products.

7. The application according to claim 6, characterized in that, The application includes at least one of the following: (1) Degrading NNK in tobacco products; (2) Reduce TSNA in tobacco products; (3) Reduce the total sugar content in tobacco products; (4) Reduce the nicotine content in tobacco products; (5) Improve the sensory quality of tobacco products.

8. The application according to claim 7, characterized in that, The sensory qualities include at least one of the following: off-flavors, irritation, aftertaste, strength, and smoothness.

9. A method for reducing the NNK content in cigar tobacco leaves, characterized in that, The microbial agent described in claim 2 is evenly sprayed onto cigar tobacco leaves and then sealed, and fermented at 33-37°C and 65-75%RH.

10. The method according to claim 9, characterized in that, The amount of the microbial agent applied to the cigar tobacco leaves is 30-40% of the dry weight of the cigar tobacco leaves to be treated, and the fermentation time is 3-5 days.